During the corresponding time, Telesis Bio Inc saw a revenue deteriorated by -68.66 % year on year, sequentially revenue grew by 30.39 %. While revenue at the Telesis Bio Inc 's corporate clients
Telesis Bio Inc's Comment on Sales, Marketing and Customers
The company provides automated multi-omic and synthetic biology solutions, including BioXp systems, to researchers in synthetic biology and next generation sequencing (NGS) markets. These solutions facilitate the rapid, accurate, and reproducible synthesis of synthetic DNA, mRNA, and short oligonucleotides for use in downstream synthetic biology applications. Market segments served include healthcare, agriculture, technology, and various consumer markets. The products support DNA and mRNA synthesis and sample preparation for NGS, enabling the discovery, development, and production of products such as antibody-based biologics, mRNA-based vaccines and therapeutics, and precision medicines.
In a groundbreaking development poised to reshape the landscape of synthetic biology, Telesis Bio, a pioneer in automated biofoundry solutions, and Beckman Coulter Life Sciences, a global leader in laboratory automation and instrumentation, have announced a collaborative effort. This alliance is set to revolutionize DNA and mRNA synthesis, delivering unprecedented capabilities in high-fidelity, scalable, and non-toxic biofoundry solutions. The Genesis of a Game-Changing PartnershipThis partnership brings together two stalwarts of the biotechnology industry, leveraging their unique strengths to address some of the most pressing challenges in bioengineering. Telesis Bio is renowned for its cutting-edge technol...
Telesis Bio Inc’s Comment on Sales, Marketing and Customers
The company provides automated multi-omic and synthetic biology solutions, including BioXp systems, to researchers in synthetic biology and next generation sequencing (NGS) markets. These solutions facilitate the rapid, accurate, and reproducible synthesis of synthetic DNA, mRNA, and short oligonucleotides for use in downstream synthetic biology applications. Market segments served include healthcare, agriculture, technology, and various consumer markets. The products support DNA and mRNA synthesis and sample preparation for NGS, enabling the discovery, development, and production of products such as antibody-based biologics, mRNA-based vaccines and therapeutics, and precision medicines.
Sources:
Telesis Bio Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Telesis Bio Inc’s corporate clients.
For your research, we’ve provided 9 tables on Telesis Bio Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
